Andere Sprachen Dignitana AB

Aktien

Verzögert Nasdaq Stockholm Andere Börsenplätze 14:42:00 24.04.2024			% 5 Tage	% 1. Jan.
1.67 ^SEK	-4.02%		-7.22%	-23.39%

04.04.	Dignitana nimmt 19 Millionen SEK durch Bezugsrechtsemission von Aktien ein	MT
07.03.	Dignicap Delta Studie in Brindisi, Italien gestartet	CI

Notice of Annual General Meeting in Dignitana AB (publ)	19.04.
Dignitana's rights issue is registered - conversion of BTA into shares	11.04.
Dignitana Raises SEK19 Million via Rights Issue of Shares	04.04.
Dignitana's rights issue fully subscribed	04.04.
Last day of trading in subscription rights in Dignitana	26.03.
Dignitana nominated for inaugural Texas Impact Enterprise Awards	25.03.
The subscription period in Dignitana's rights issue starts today	18.03.
DigniCap Delta study underway in Brindisi, Italy	07.03.
Dignicap Delta Study Underway in Brindisi, Italy	07.03.
Dignitana invited to address MedTech innovation on panel at SXSW® conference in Texas	05.03.
Dignitana to exhibit at Onkologidagarna in Malmö	29.02.
Notice of Extraordinary General Meeting in Dignitana AB (publ)	22.02.
Sweden's Dignitana to Raise SEK19 Million via Rights Issues, Secures SEK5 Million Bridge Loan	22.02.
The Board of Directors of Dignitana resolves on rights issue, obtains bridge loan, and calls for Extraordinary General Meeting	21.02.
Dignitana newsletter presents accelerating growth in US and around the globe	19.02.
Dignitana CEO Catarina Löwenadler interviewed by Redeye	16.02.
Dignitana Q4’23 - Positive momentum into 2024	16.02.
Correction of press release: Dignitana AB Publishes Q4 2023 Interim Report	15.02.
Dignitana AB Publishes Q4 2023 Interim Report	15.02.
Dignitana AB Reports Earnings Results for the Full Year Ended December 31, 2023	15.02.

Keine Ergebnisse zu dieser Suche